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Abstract
A great challenge for modern cell biology is the successful examination of the co-expression of thousands of genes under
physiological or pathological conditions and how the expression patterns define the different states of a single cell, tissue or
a microorganism. Gene expression can be analyzed today on a large scale by advanced technical approaches for differential
screening of proteins and mRNAs. The identification of differentially expressed mRNAs has been successfully applied to
 .understand gene function and the underlying molecular mechanism -s of differentiation, development and disease state.
Analysis of gene expression by the systematic mapping of thousands of proteins present in a cell or tissue can be achieved
 .by the use of two-dimensional 2D gel electrophoresis, quantitative computer image analysis, and protein identification
techniques. In this article, we comment on some of these techniques and try to stress their advantages and drawbacks. We
show how data from RNArDNA mapping, sequence information from genome projects and protein pattern profiling can be
linked with each other and annotated. These comprehensive approaches permit the study of differential gene and protein
expressions in cells or tissues. q 1997 Elsevier Science B.V.
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1. Introduction
An integrated view of differentially expressed mR-
NAs and protein expression profiles of various cell
types may be a prerequisite in understanding how
different control mechanisms operate under normal
physiological and abnormal conditions. In the haploid
human genome, 3=109 base pairs of DNA are
w xdistributed in 23 distinct chromosomes 1 . From the
estimated 50 000–100 000 genes, only a fraction is
expressed in a distinct cell type at any given time,
giving rise to about 5000 different proteins, together
with their modified variants. A vast number of pro-
teins are specifically expressed at every developmen-
tal stage and each tissue in the body is characterized
by hundreds of unique proteins. There are more than
w x250 different cell types in the adult body 1 , each
one differing from others by expression of about
300–400 specific proteins. However, it is estimated
that 35–80% of all proteins in vertebrate cells will be
conserved from tissue to tissue, constituting marker
proteins, such as enzymes involved in glycolysis,
DNA modifications and proteosynthesis. The analysis
of gene expression by protein pattern profiling can be
achieved by the use of high resolution two-dimen-
 .sional 2D gel electrophoresis. This has allowed the
quantitative and qualitative expression analysis of up
to thousands of proteins simultaneously and has been
successfully used to examine altered gene expression
patterns in a disease status and under different envi-
w xronmental conditions 2–4 .
The expression of mRNAs is complex, inasmuch
as 20 000–30 000 distinct mRNAs are estimated to be
w xpresent in a single cell 5 . From these, 99% are
considered to be rare, with a prevalence of
1r20 000–1r70 000 and represent roughly 50% of
total mRNA. Consequently the remaining mRNAs
comprise a relatively small number of abundant
species. Therefore, methods were developed to iden-
tify a differentially expressed mRNA independent of
its frequency in a given mRNA population. Among
 .the techniques discussed, Differential Display DD
w xof mRNA is 6 a very promising one. This utilises
the polymerase chain reaction with arbitrary and
polyT-anchored primers to generate thousands of
cDNA species, each of which correspond to an ex-
pressed gene, seems to be a very promising.
2. Differentially expressed mRNA
( )2.1. Differential display DD
 .Differential Display DD is a commonly used
technique to estimate the number and identity of
genes that are differentially expressed under specified
conditions. DD relies on RT–PCR amplification of
expressed mRNAs exploiting many combinations of
primers. A major advantage of DD is the possibility
to compare several samples simultaneously and to
detect loss as well as gain of cDNA populations on
the same gel.
DD was used to analyze changes in gene expres-
sion in numerous experimental setups, comparing,
e.g. normal vs. tumor cells, healing epithelium vs.
stationary cells, cells at different stages of neonatal
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development, tissues from siblings which may be
affected by an inherited genetic disorder, etc. The
aim of a successful DD screen in general should not
restrict itself to cataloging differentially expressed
genes but to identifying those which are truly respon-
sible for appearance of structural and functional
changes.
What are then the crucial requirements affecting a
successful DD screen? First of all, it is the choice of
the right starting material. Samples to be analyzed by
DD should be closely related, e.g originating from
the same organism, tissue, ideally the same cell type
and affected only by the experimental treatment,
disease or other specific influence which is the direct
aim of the study.
On the other hand, when two unrelated samples
are compared e.g. freshly isolated tissue vs. estab-
.lished cell line vast numbers of differentially ex-
pressed genes could be detected. However, numerous
of these ‘‘differentially’’ expressed genes are only
artifacts caused by the sample diversity. Therefore, as
a part of each DD screen, the relationship between a
gene detected by DD and its function in the particular
experimental situation has to be confirmed by a series
of stringent control experiments.
2.1.1. Currently used techniques
2.1.1.1. Choice of DD primers. Several factors affect
the number of differentially expressed genes de-
tectable by DD. The number of differences in band
patterns reflects, among other factors influencing the
reaction, the efficiency of the primer set. According
to a study where the authors analyzed 240 primer
 Xcombinations 12=3 T-rich primers combined with
X . w x20=5 arbitrary primers 7 , the efficiency of a
primer set depends not on the 5X primers but mostly
on 3X T-rich primers and principally on the last two 3X
bases of the T-rich primers. This was shown in a
comparison of two studies where the authors used
almost identical, low stringency PCR conditions. One
group used the T VA type anchored primers, where12
w xV stands for a degenerated mix of A, C, and G 5
and found on average 1 out of 2 bands as a true
positive. In the other study, where the 5X T -CA 3X11
anchored primer was used only one out of six iso-
lated DNAs was in fact differentially expressed. Two
other fragments did not hybridize on Northern blots,
one encoded a portion of 18S ribosomal RNA, and
w xtwo were present in all samples 8 . In yet another
study, the authors used 12 combinations of primers
 X .three anchored and four 5 primers , and found a
total of 30 fragments. However, Northern blot analy-
sis confirmed only a single gene being differentially
w xexpressed 9 , and in this case the anchored primer
was also of the T CC type. In principle, it was11
shown that the higher the number of primer sequence
variations designed, the bigger is the chance for
identification of truly differentially expressed genes.
It was observed that oligonucleotides which end
with G or C or have Gs andror Cs in the last two
w xbases prime more efficiently 5,10 . However, three
or more Gs or Cs located at the 3X end of a primer
negatively affect priming specificity. Primers with
 . Xstable CrG 3 ends usually give poorer repro-
w xducibility 11 . Interestingly, almost all inefficient
primer combinations were unsuccessful due to the
choice of their 3X primer. When the complementarity
between gene sequences and the arbitrary 5X primer
10-mers was determined, mismatches occurred more
frequently toward the 5X end of the primer. However,
certain level of mismatches is desirable because only
a limited number of primers is used to amplify many
w xbands 11 .
The choice of primers can affect the overall DD
w x Xresult at two levels 12 . First, if several 3 anchored
T-rich primers hybridize in the RT step to the same
mRNA, similar cDNA is synthesized in parallel reac-
tions. Second, additional redundancy may occur if the
last four 3X bases of the 5X arbitrary 10-mer are
identical. In this case, different 5X primers may hy-
bridize to the same region. Therefore, the last four
bases at the 3X ends of 10-mers have to be designed
w xas diverse as possible 5 . A valuable control in a
PCR reaction is the use of primer alone, as it was
experimentally established that 5X primers on their
own may cause amplification of primary PCR arti-
w xfacts 13 .
When combinations of 3X anchored degenerated
primers of the T VA, T VC, T VG type with 20–2712 12 12
different arbitrary decamers as 5X primers were used,
one truly regulated gene out of three to seven candi-
w xdate bands 14–16 could be identified.
In an attempt to increase the reproducibility of the
DD protocol, while preserving its high efficiency,
w x XZhao et al. 11 designed new set of 3 composite
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anchored primers and 5X composite arbitrary primers.
The original DD primers were modified by an addi-
tion of a 10-mer at the 5X end. Primers were also
improved by incorporation of an EcoRI restriction
site to facilitate subcloning of the PCR products.
Although both, anchored and arbitrary primers had
virtually identical 10-mer on their 5X end, the band
display changed with different combinations of
primers, which indicated that each pair of primers
had its own priming efficiency. Linskens et al. also
w xused longer, 22 nucleotide primers 7 . Besides the
presence of a HindIII restriction site used for cloning,
22 nucleotides long primers allowed direct sequenc-
ing of PCR products. Still, about one half of the
resulting bands could not be directly sequenced be-
cause of contamination with other sequences of a
very similar size that were not sufficiently resolved
by the gel. In another modification of the DD proto-
col were used for the re-amplification of DD cDNA
bands primers extended at their 5X ends by 8–9 bases
w x17 . However, as in the previous example, due to the
complexity of the banding pattern some PCR prod-
ucts had to be subcloned. In yet another DD protocol,
in the PCR amplification step were used instead of
w xanchored primer two different arbitrary primers 13 .
This improvement removed ‘‘shading’’ from the gel
and increased resolution.
While choosing the right combination of primers,
it is important to keep in mind what is the aim of the
study. When the goal is to find a new member of an
already known gene family, then it is possible to use
only a small number of primer combinations and to
design ‘‘biased’’ primers based on common motifs
from families of related genes. This reduces the
possibility of random priming, but on the other hand
also diminishes the chance that in the studied biologi-
cal system an unpredicted candidate gene will be
w xfound 18 .
Opposite situation is in the case when the final
goal of the study is to identify maximum possible
number of differentially expressed genes in a given
system. In all DD protocols are losses in number of
different mRNAs due to technical reasons total RNA
isolation, reverse transcription and subsequent han-
.dling of samples . In order to cover a broader spec-
trum of mRNAs expressed in a cell at a time it is
advisable to use higher number of primer combina-
tions. Wider selection of arbitrary primers increases
the chance of priming to different locations of the
same sequence and, therefore, better identification of
a potentially important candidate gene.
2.1.1.2. Enhanced DD PCR conditions. In order to
enhance efficiency of detecting true positives, a two-
step PCR reaction was introduced Enhanced Differ-
. w xential Display protocol, EDD 7 . In EDD, four
initial rounds with low stringency annealing tempera-
ture of 418C were followed by 18 cycles at an
elevated temperature of 608C. As a result of this
strategy, the reproducibility of banding patterns im-
w xproved significantly. Zhao et al. 11 used a modified
 .PCR protocol, where one low-stringency step 408C
was followed by 30 high-stringency steps 608C for
.annealing . This modified protocol significantly im-
proved the sensitivity of DD. The reason for this
improvement is that when only one low stringency
 .step 408C for annealing is used this allows less
frequent mispairing between the long arbitrary primer
and the cDNA templates.
2.1.2. Selection of controls for differential display
It is advisable to include both, internal controls of
w x the DD technique itself 18 e.g. different concentra-
tions of the RNA template, or RNA isolated at differ-
.ent time points , and independent experimental ap-
proaches confirming the putative involvement of the
candidate gene in the regulation of the system under
study, as well. The possible heterogeneity of the
starting material and the general susceptibility of
PCR to artifacts require careful confirmation. North-
 .ern blot NB analysis is the most commonly used
technique for the confirmation of the differential
nature of expression of a candidate PCR product. As
for example in the case of a DD screen designed to
identify genes repressed or amplified in tumors, RNA
samples isolated from tumor biopsies of different
patients could serve as external controls. In such a
DD screen authors have compared RNAs isolated
from cell lines derived from normal and tumor lung
w xtissues 9 . Out of 30 DNA fragments which they
originally selected from the DD gel, only one showed
differential mRNA expression on Northern blots pre-
pared with RNA from normal versus tumor cells.
Nevertheless, a word of caution has to be raised
when Northern blotting is used for DD confirmation,
since this technique has several weaknesses. First, the
( )I. Vietor, L.A. HuberrBiochimica et Biophysica Acta 1359 1997 187–199 191
sensitivity may be insufficient. This could be over-
come by resolving increasing loads of tested RNA on
the gel. When sufficient amounts of RNA are not
available, large quantities of so called aRNA could be
w xprepared by a RNA amplification protocol 19 , al-
though fidelity of such material remains questionable.
Secondly, DD products are based on 3X sequences of
analyzed RNAs since polyT primers are used for the
initial RT step of DD. Since many 3X non-coding
regions are not available in the GenBank, it is diffi-
cult to identify these DD products. In order to in-
crease the validity of Northern analysis, Linskens et
w xal. have improved their DD protocol 7 and used in
the case of already known genes as NB probes
40-mer oligos, that were complementary to the 5X
coding region available in the GenBank. With large
sample numbers, Northern blotting becomes the most
time consuming part of the DD protocol. An alterna-
tive technique is the ‘‘reverse’’ Northern blotting
w x20 . In this protocol, all candidate genes are spotted
on duplicate membranes in a form of aliquots of
either PCR products or already cloned plasmid DNAs.
These are hybridized with a radioactively labeled
complex cDNA probe made by RT–PCR of total
 .  .RNA isolated from a uninduced and b induced
cells. ‘‘Reverse Northern’’ blotting technique be-
comes namely efficient when combined with cloning
of cDNA fragments into a cloning system like pCR-
w xTRAP 20 , which is based on positive selection for
inserts. However, this technique does not provide
with any higher sensitivity than regular Northern blot
and secondly does not inform about the size of the
message. On the other hand, ‘‘reverse’’ Northern blot
allows simultaneous testing of hundreds of different
w xDD cDNAs, with smaller amounts of RNA 21 and
similar sensitivity. Alternative screening techniques
for differentially expressed PCR products of DD as
partial DNA sequencing, single-strand conformation
 .polymorphism SSCP , or restriction enzyme diges-
tion using two 4-cutters 128 bp theoretical fre-
. w xquency were published by Zhao et al. 22 . However,
because of unpredictable cutting sites the enzyme
digestion method may not guarantee a successful
classification of cDNA clones. All these techniques
simplify and speed up initial screening of multiple
colonies with cloned-in cDNA fragments. Although
partial DNA sequencing is more time consuming than
SSCP method, it is more reliable because of the
w xcomplex pattern it generates 22 . However, for the
final confirmation of differential expression of a DD
PCR candidate is always used Northern blot. Unfor-
tunately, Northern blot is not only labour costly but
also requires large amounts of RNA.
2.1.3. Examples of the successful use of differential
display
As one example of a study where differential
display was successfully used, we can mention the
analysis of differential gene expression induced by
different PKC isozymes, in several clones of NIH
3T3 cells stably transfected with various PKC iso-
w xforms 8 . As a result of this DD search an immediate
early gene titled ST2rT1 was identified, which is
constitutively expressed in cells overexpressing PKC-
b II, yg, yz, and ym but not in cells overexpress-
ing PKC-a only. Another example is a successful
DD search for genes overexpressed in senescent hu-
 . w xman mammary epithelial cells HMEC 23 . In this
study, the authors compared normal-, immortal-, and
tumor-derived HMECs, all derived from 76N cells, a
strain established from an individual mammoplasty.
A potential tumor-suppressor gene M PL
 .mitochondria proteolipid like gene was identified
by DD when samples from normal liver cells were
compared with cell lines derived from human hepato-
 . w xcellular carcinoma HCC tumors 24 . Another gene,
a member of the IGFBP Insulin Growth Factor
.Binding Protein family, called mac25, was found by
DD as a down-regulated gene in mammary carci-
noma cell lines suggesting its tumor suppressor role
w x23 . To better understand functional differences be-
tween less and more mature bone marrow, eight
differentially expressed genes were identified by DD
in CD38 low- and CD38 high-expressing progenitor
w xcells 25 . In an animal model of disease, DD was
used for the identification of changes in gene expres-
sion during neointima formation following an artery
w xballoon angioplasty of rat carotid vessels 26 .
In another study, DD was successfully applied to
understand the pathogenesis of type II citrullinemia
w x27 , a disease typically caused by decreased hepatic
activity of the enzyme argininosuccinate synthetase
 .ASS . However, there exists an adult-onset form of
type II citrullinemia, in which neither a decrease in
ASS protein amount, nor structural abnormalities or
mutations are obvious. A DD screen revealed an
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additional differentially expressed cDNA band in liver
samples from type II citrullinemia patients. This DD
product was cloned, sequenced and shown to be 99%
homologous over ;300 bp with the human pancre-
 .atic secretory trypsin inhibitor hPSTI . Increased
hPSTI mRNA expression was confirmed by Northern
Blotting and RT–PCR. Furthermore, concentration of
hPSTI protein was found to be higher in the liver of
type II citrullinemia patients than in healthy controls.
Still more experiments will be required to address an
exact molecular mechanism for the involvement of
hPSTI in the late onset of type II citrullinemia.
In a search for p53-transactivated genes in etopo-
side-induced apoptosis, EI24 was identified by DD
w x28 . EI24 was up-regulated not only in the etopo-
side- but also by ionizing radiation-induced apoptosis
and this was later proved to be p53-regulated. Fur-
thermore, a homologous protein was found in C.
elegans, which suggests its evolutionary conserved
role. However, as in the previous examples, this
study has not yet proven a direct link between the
gene identified by DD and its role in the studied
process.
Transgenic mice expressing large T-antigen of
polyomavirus metalloprotein promoter-regulated;
.MT-PVLT develop testicular tumors at advanced
age. By DD analysis a cDNA fragment corresponding
w xto the Fas antigen receptor 29 was found in cell
lines derived from normal testicular cells but not in
immortalized cell lines derived from adenomatous
testis of these mice. The differential expression of
Fas antigen receptor was confirmed by RNAse pro-
tection assay. Since IFN-g treatment causes up-regu-
lation of the Fas antigen receptor gene, the authors
were able to show that tumor cells do not respond to
IFN-g treatment and are, therefore, less susceptible to
the anti-Fas antibody-mediated cell death in vitro.
Flow cytometry showed an accumulation of cells in S
phase of the cell cycle which suggests that the loss of
Fas antigen receptor expression may be involved in
multistage carcinogenesis in the transgenic MT-PVLT
w xmouse model 29 . This study may serve as an exam-
ple where a principle role for a gene initially identi-
fied by the differential display technique was con-
firmed.
Finally, DD can also be applied to establish a
systematic catalog of all genes typically expressed in
w xa given cell type or a tissue 7,23 , provided that lab
capacity and available equipment are not limiting.
DD was used for this purpose in order to generate a
catalog of genes that are differentially expressed in
 .young and senescent human diploid fibroblasts HDF
w x7 . In this model system replicative senescence, a
crucial mechanism in aging of organisms, can be
studied. From 168 genetags initially identified, 84
could be sequenced directly from PCR amplified
bands. Northern blot analysis confirmed differential
expression of 11 novel and 12 already known genes.
Several of the known genes had been previously
observed to be differentially expressed in young and
senescent fibroblasts, thereby confirming the reliabil-
w xity of this technique 7 . Although this DD-based
catalog of differentially expressed genes in senescent
cells is quite comprehensive, several genes, already
known to be differentially regulated in senescent
cells, could not be found by DD. One possible expla-
nation may be the fact that PCR reactions detected
only the most abundant mRNAs, because 10-mer
oligonucleotides were used as arbitrary primers and
PCR reactions were performed at low stringency
annealing temperature of 408C.
( )2.2. Representational difference analysis RDA
 .In representational difference analysis RDA , two
populations of DNAs are compared by the combina-
tion of subtractive hybridization and a subsequent
PCR-based enrichment of DNAs which represent dif-
ferences between the two compared samples. RDA
was originally devised to isolate the genomic regions
w xwhich are different in two DNA populations 30 .
PCR-coupled subtractive process of RDA has been
w xlater adapted by Hubank and Schatz 31 for use with
cDNA this technical modification should be there-
.fore called cDNA RDA . As opposed to differential
display, which amplifies fragments from all template
molecules, RDA eliminates those fragments present
in both populations, leaving only differences. In the
first RDA step, the two compared samples are di-
gested with a restriction enzyme to form so called
‘‘representations’’. Selecting representations from the
samples reduces their complexity and increases accu-
racy of the following subtraction processes. However,
on the other hand, reduction of complexicity causes
also loss of some information. Two populations of
representations compared are ligated with two differ-
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ent primer types in order to be PCR amplified in the
last experimental step. In the second step are hy-
bridized the so called ‘‘tester’’ sample containing
. unique sequences and ‘‘driver’’ DNA or cDNA
.added to the hybridization reaction in abundance
representations. Unique fragments present only in one
representation are subtracted in the presence of ex-
 .cess of the driver usually up to 1000:1 . The target
hybridizes to itself and retains the ability to be ampli-
fied by PCR, which is the last step of the RDA
 . w xcDNA RDA protocol 31 . Since RDA, in contrast
to DD, is unable to identify loss and gain of gene
expression simultaneously, two methods exist how to
apply RDA when searching for differences, e.g.
.between normal and tumor cells . First, tumor DNA
is used as the so called driver and normal DNA as
tester. When genomic DNAs were compared by RDA
in this experimental setup, six deleted genomic re-
w xgions were identified in cultured cancer cells 30 .
Southern blot and PCR analysis confirmed frequent
homozygous loss of these sequences in many tumor
w xcell lines 32 . Second, the reverse experimental setup
– where normal DNA serves as driver and tumor
DNA as tester – is used when the focus of interest
lies in sequences amplified in tumors, namely onco-
genes. In a case when the tumor DNA was used as a
tester, cDNA RDA could detect 30–100-fold amplifi-
cations of individually cloned products already after
w xthe second round of hybridization and selection 32 .
Single short sequences, present only in one of two
highly related genomes, can be identified with RDA.
The inventors of RDA stated, that the power of RDA
is so great that after three rounds of selection the total
enrichment could be as high as 1010. Unfortunately,
this is not always true, as PCR tends to amplify
w xprimarily very abundant templates 32 . Therefore, in
order to increase sensitivity and enrich RDA prod-
ucts, these can be cleaved, new PCR adaptors added,
mixed with fresh drivers, and the hybridization–
amplification steps repeated. cDNA RDA was suc-
cessfully applicated in various research areas. Several
novel viral agents originating from an infected human
individual and causing hepatitis in experimentally
infected primates were isolated, cloned, and subse-
w xquently analyzed using cDNA RDA 33 . In yet
another study, cDNA RDA was employed in identifi-
cation of genes transcribed in response to EWSrFLI,
structurally altered transcription factor implicated in
w xoncogenesis 34 . Eight transcripts that are dependent
on EWSrFLI for expression and two transcripts that
are repressed in response to EWSrFLI were charac-
terized. RDA and modified RDA, respectively, were
successfully used for the identification of genes dif-
ferentially expressed in specific cancer models as e.g.
Eker rat hereditary renal carcinoma and Yoshida
w xsarcoma 35,36 .
An obvious drawback of RDA is the inability to
compare more than two samples at the same time.
Secondly, RDA finds by definition only differences
in representations equivalent to certain fragments of
sequences. This is given by the nature of the specific
restriction endonuclease digestion and also because
PCR amplification in general favours fragments
shorter than 1.0 kb, the average size of representa-
w xtions is typically between 250 and 350 bp 30 . Like-
wise, if PCR amplified single-stranded cDNA would
be used to generate a cDNA library, certain cDNAs
w xwould be underrepresented 5 . Therefore, in order to
exploit all differences between two samples, it is
advisable to use combinations of several different
restriction endonucleases. Yet, another problem with
RDA is that depending on which combination of
restriction enzymes was used for the initial cleavage
of the starting material, some amplicons were less
effective than others. As demonstrated by authors in
w x30 HindIII was better than Bgl II. This problem
could be partially mastered by additional rounds of
 .RDA. In cDNA RDA, reverse transcription RT of
RNA samples isolated from tester and driver cell
populations preceding RDA adds another level of
complexity. Nevertheless, a clear advantage of RDA
over DD is the possibility to add to the driver those
sequences which are not wanted to be identified.
Without some simplification of the driver complexity,
subtractive and kinetic enrichments are diminished
w xand competing processes will dominate 30 . The
target gene must be unique as DNAs that belong to a
gene family may be subtracted by a closely related
member. Similarly, when a particular mRNA is up-
regulated but still present in the driver, it may go
w xundetected 5 . Unfortunately, due to its sensitivity,
RDA is also prone to contamination by DNAs origi-
nating from other sources then the tester itself. These
can stem from surrounding tissue or cells, environ-
 .mental contaminations e.g. bacteria or microbes or
even previous PCR products. All these contaminating
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sequences will be readily enriched if they are absent
w xin the driver 37 . Therefore, the presence of each
RDA product has to be confirmed in both tester and
driver by independent techniques.
( )2.3. Serial analysis of gene expression SAGE
In the case when the main goal of the study is to
catalog all mRNAs typically expressed in a given
population of cells or in a distinct tissue Serial Anal-
 . w xysis of Gene Expression SAGE 38 presents an
alternative technique. This protocol is based on iden-
 .tification of ESTs Expressed Sequence Tags which
are publicly available in GenBank on World Wide
 .Web www . Using SAGE, numerous short diagnos-
tic tags can be sequenced simultaneously. In this
experimental procedure, double stranded cDNA is
 .synthesized from mRNA using biotinylated oligo dT
primers. Resulting cDNA is cleaved with the
‘‘anchoring’’, class II restriction enzyme. Most 3X
portion of the cleaved cDNA is isolated with strepta-
vidin beads. This way transcripts closest to the polyA
tail are created. The sample is divided into half and
ligated through the anchoring restriction site to one of
two linkers containing a so called ‘‘tagging’’ restric-
tion site. Cleavage of the ligation products with the
tagging enzyme produces linkers with a short piece
of the cDNA. Two pools of tags are ligated to each
other and serve as templates for PCR reaction primers
specific to each linker. The resulting amplification
 .products contain two tags one ditag linked tail to
tail, flanked by sites for the anchoring enzyme.
Cleavage of the PCR product with the anchoring
enzyme allows isolation of ditags that can be se-
quenced for the scheme of the complete procedure
w x.see Ref. 38 . Information from two sets of SAGE
can be compared by means of so called Electronic
Subtraction and this should, at least in theory, lead in
a fast and efficient way, to the detection of genes that
are differentially expressed in two samples under
investigation. Based on calculations, nucleotide tags
in principle as short as 9–13 bp, contain sufficient
w xinformation to uniquely identify a transcript 38 . In
theory, a 9 bp sequence should be sufficient to distin-
w xguish 262 144 transcripts 38 , given a random nu-
cleotide distribution at the tag site, whereas current
estimates suggest that even the human genome en-
w xcodes only about 80 000 transcripts 38 . These tags
are located at the 3X end of analyzed sequences and,
therefore, their analysis depends on the availability of
EST data in the WashU-Merck EST cDNAs database
w x X X5 , which contains both 5 and 3 sequences. This
technique tracks only a single sample and, therefore,
any kind of subtraction is extremely dependent on the
quality and reproducibility of the sample preparation.
Since SAGE gives useful and reliable data only when
thousands of short nucleotide tags from each sample
are sequenced it can be the technique of choice only
for a laboratory which is technically equipped for
automated sequencing. Similarly, ‘‘Electronic Sub-
traction’’ of data acquired by SAGE obviously re-
quires access to high computational power. As an
example of a successful application of SAGE we can
mention the characterization of pancreatic gene ex-
w xpression patterns 38 .
2.4. Computerized data analysis
Whatever technical approach is applied to search
for a differentially expressed sequences DD, RDA,
.or SAGE , the ultimate goal of each study is to
identify the gene and its link to a biological function.
Therefore, each investigator is looking for an exhaus-
tive, reliable and fast match of the new sequence with
the information available in the public domain
database. From the software point of view the two
commonly used programs are FASTA and BLAST.
Both take an unknown sequence and compare it to
known sequences, looking for the best possible match.
FASTA compares the new, unknown sequence with
longer stretches of currently known sequences and
this makes this program rather slow but more accu-
rate than BLAST. The latter program scans for short
stretches of nucleotides or amino acids that are simi-
lar but not necessarily identical. If the match is
sufficiently close, BLAST proceeds in both direc-
tions, comparing longer stretches. The most recent
version of BLAST also takes into account small
insertions or deletions of amino acids. Today, there
are many different services available on the World
 .  .Wide Web www Table 1 . Among those which are
constantly improving is the service provided by the
National Center for Biotechnology and Information
 .NCBI available at http:rrwww.ncbi.nlm.nih.govr.
From the vast range of services currently provided by
NCBI we can mention for example just the latest
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Table 1
Addresses of selected Genome-related Information Services available on the www
aName and type of database URL
Johns Hopkins University BioInformatics Web Server http:rrwww.gdb.orgrhopkins.html
CSL – Community Sytems Laboratory with ENQUire http:rrcsl.ncsa.uiuc.edurCSLWWWrENQUire.html
EMBL – European Molecular Biology Laboratory http:rrwww.embl-heidelberg.de
European Structural Biology http:rrwww.cryst.bbk.ac.ukrCECreupage.html
ExPASy – Molecular Biology Server Univ. of Geneva http:rrexpasy.hcuge.ch
NIH – Home Page http:rrwww.nih.govr
NIH - Cyber Science http:rrmolbio.info.nih.govr
NCBI – GenBank and Entrez http:rrwww.ncbi.nlm.nih.govrWebrSearchrindex.html
NCBI – in general http:rrwww.ncbi.nlm.nih.govr
PDB – Brookhaven Protein Data Bank Gopher gopher:rrpdb.pdb.bnl.govr1
PDB – Brookhaven Protein Data Bank www Server http:rrwww.pdb.bnl.gov
Pedro’s BioMolecular Research Tools http:rrwww.public.iastate.edur;pedrorresearch_tools.html
SCOP – Structural Classification of Proteins http:rrwww.pdb.bnl.govrscopr
GenBank – NIH genetic sequence database http:rrwww.ncbi.nlm.nih.govr
Nucleic Acid Database at Rutgers University http:rrndbserver.rutgers.edu:80r
TIGR, The Institute Genomic Research http:rrwww.tigr.orgr
GenoBase Database Gateway Server at NIH http:rrspecter.dcrt.nih.gov:8004r
‘‘FlyBase’’ – 5 Drosophila Genome Databases http:rrmorgan.harvard.edur
Biology Workbench http:rrbioweb.ncsa.uiuc.edur
upgrades, e.g. Cn3D – a 3D structure viewer for
MacIntosh, complete E. coli genome, complete
Methanococcus jamnaschii genome, THC s
Tentative Human Consensus Sequences, Electronic
PCR Human Gene Map, Open Reading Frame Finder,
Batch Entrez and many others. All these services are
connected via dynamic links allowing fast and effi-
cient search from the sequence data to structure
predictions to the possible function and links to the
list of possible disease-causing mutations, as well.
With the development of the web-programming lan-
guage Java the opportunity arose to link software
running on computers with previously incompatible
operating systems and at various locations. This al-
lows the user to download and use tools located on a
remote server. This technology is the basis of the
Biology Workbench, developed and located at the
National Center for Supercomputing Applications at
the University of Illinois at Urbana-Champaign
 .NCSA . The service is available at the following
address: http:rrbioweb.ncsa.uiuc.edur. Biology
Workbench is a point and click web interface that
provides access to databases and analysis tools for
biological investigations. The obvious advantage of
the Biology Workbench are its links to many interest-
ing sites around the world. However, to use the
workbench more knowledge of the system is required
which is less user-friendly than NCBI’s BLAST ser-
vices. The real current drawback of the web-based
technology are the ever more common ‘‘traffic jams’’
on the www.
3. Protein pattern profiling
3.1. 2D-gel mapping
Analysis of gene expression with the help of pro-
tein studies in specific cell or tissue types presents a
powerful complementation to the nucleic-acid based
technology described above. To define protein-based
gene expression analysis, the term ‘‘proteome’’ was
w xrecently proposed 39 . A proteome is the entire
PROTein population expressed from a genOME, or
of any cell or tissue type at a given time. Therefore, a
proteome is an entity that can change under different
conditions, and can be dissimilar in different tissues
of a single organism, yet is the direct product of a
genome. The number of proteins in a proteome can
exceed the number of genes present, as one mRNA
can give rise to several protein products e.g., from
alternative splicing or posttranslational modifications
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which are detectable on a gel. The analysis of com-
plex patterns of protein expression has been substan-
tially improved since the development of two-dimen-
 .sional 2D gel electrophoresis by which proteins are
 .first separated according to their charge p I in one
direction and subsequently by their molecular weight
w xin the second direction 40 . Today’s 2D-gel analysis
allows the quantitative and qualitative expression
analysis of thousands of proteins simultaneously. This
sophisticated technique for example permitted the
w xseparation of all the proteins present in E. coli 41 ,
w xor in a yeast cell 42 . Mammalian cells, however, are
likely to express more proteins than a standard 2D-gel
can routinely resolve. Computer software has been
designed that enables rigorous qualitative and quanti-
tative analysis of protein expression on digitized 2D-
w xgels 4,43 . Using these programs one can match and
catalog large numbers of 2D-gel patterns, thereby
w xbuilding comprehensive databases 44,45 . The power
of this approach is even enhanced when combined
with other technical approaches, e.g. Western im-
munoblotting, transient expression of cDNAs, protein
micro-sequencing and amino acid analysis. Todays
2D-gel protein databases are linked with each other
as well as with international specialized data banks of
nucleic acid and protein sequences, genomic maps,
protein structures and NMR data.
A prerequisite for separation and comparison of
complex protein mixtures by 2D-gel electrophoresis
is high resolution and reproducibility of gels. The
 .development of immobilized pH gradients IPGs on
strips for isoelectric focusing has largely solved the
issue of 2D-gel reproducibility, allowing intra- and
inter-laboratory comparison of separated protein pro-
files. The pH-gradient is applied as a gel bonded to a
plastic backing and is run horizontally. In classical
 .isoelectric focusing IEF the key to reproducibility
of the system lied simply in the choice and mixture
of ampholines, whereas IPG-strips are commercially
available and exist in a variety of pH gradients linear
. w xvs. nonlinear, gradient intervals etc. 46 . Their us-
age results in higher reproducibility, representing a
very important step forward in standardization of the
procedure. Furthermore, in order to resolve rather
 .basic proteins p I)7.5 the same strip can be used
for both anodic and cathodic sample application. This
offers an interesting alternative to the technically
 .demanding non equilibrium gels NEPHGE in the
ampholine carrier system. In addition, IPGs have a
higher loading capacity both in terms of protein
.amounts as well as of sample volume , which greatly
facilitates micro sequencing and amino acid analysis
w x47 . The advantage of IPGs is rising since growing
number of laboratories is using them for their 2D-gel
work.
There are two ways to electrophoretically separate
proteins in the second dimension: vertical slab gels
and ultra-thin horizontal gels. Both are usually SDS-
 .containing gradient gels e.g. 9–16% acrylamide
which separate proteins in the molecular weight range
of 5–200 kD. A stacking gel which is usually not
used with slab gels is necessary in horizontal gels.
Both approaches are highly reproducible but for oc-
casional users commercially available horizontal pre-
cast gels provide greater reproducibility. Proteins can
be detected by different methods e.g., Coomassie-,
.silver-staining, or autoradiography depending on the
purpose of an experiment and the sensitivity required.
3.2. 2D-gel reference maps
Following 2D-gel electrophoresis and protein visu-
alization, e.g. by silverstaining or autoradiography,
images are digitized for computer analysis by a laser
densitometer, phosphor-imager or other scanning de-
vice. For detectable proteins estimated molecular
masses and isoelectric points are calculated, and pro-
tein spots can be compared and quantified. For pro-
teome projects, the aim of the analysis is to catalog
all proteins from 2D-gels of different biological sam-
ples in a qualitative and if possible also quantitative
manner, so as to define the number of proteins pre-
sent and their respective levels of expression. Refer-
ence gel maps constructed in this manner form the
basis of 2D-gel databases. These maps can be used to
investigate the levels of synthesis of thousands of
polypeptides in any organism or tissue and hence
serve as a direct way of relating genomes to pro-
w xteomes 3,4,39,48 . Today, increasing numbers of
reference maps are accessible through the www and
are available for free for the scientific community
 .Table 2 . Since this involves matching of several
thousands of proteins between two or more gels,
sophisticated image analysis systems with high ca-
pacity are required.
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Table 2
 .Two-dimensional gel databases accessible through the www and their universal resource locator URL addresses
aName and type of database URL
HSC-2DPAGE http:rrwww.harefield.nhthames.nhs.ukrnhlirproteinr
 .human, dog and rat heart databases
SWISS-2DPAGE http:rrexpasy.hcuge.chrch2drch2d-top.html
10 human samples, Escherichia coli and Sacharomyces cere˝isiae
.databases
Argonne Protein Mapping Group http:rrwww.anl.govrCMBrPMB
 .mouse liver and breast cell databases
CSH Quest Protein Database Centre http:rrsiva.cshl.orgr
 .rat fibroblast, musoe embryo and S. cere˝isiae databases
Danish Centre for Human Genome Research http:rr130.225.13.134rcgi-binrmake-home start
keratinocyte, cell carcinoma, urine and many other human tissues
.and fluids
E. coli Gene–Protein Database http:rrpcsf.brcf.med.umich.edureco2dbaser
HEART-2DPAGE http:rrwww.chimie.fu-berlin.deruserrpleissrdhzb.html
 .human heart database
Large Scale Biology Rat Liver Database http:rrwww.lsbc.comr2dmapsrpatterns.html
Proteome Inc. YPD http:rrwww.proteome.comrYPDhome.html
YEAST-2DPAGE http:rryeast-2dpage.gmm.gu.ser
Yeast Protein Map http:rrwww.ibgc.u-bordeaux2.frrYPMraccueil.html
 .S. cere˝isiae protein database
a Five rules have been proposed to standardize two-dimensional gel databases. Fully federated databases adhere to all rules, partially
federated databases adhere to some, but not all rules For further references see: R.D. Appel, A. Bairoch, J.C. Sanchez, J.R. Vargas, O.
 . .Golaz, C. Pasquali, D.F. Hochstrasser, Electrophoresis 17 1996 540–546.
3.3. Identification of proteins
Protein samples can usually be identified by a
number of techniques such as micro sequencing,
peptide mapping, amino acid composition analysis,
2D-Western blotting, immunoprecipitation and tran-
sient overexpression of cDNAs. However, alternative
techniques could serve as useful first pass methods in
w xan integrated approach for protein identification 3 .
The obvious first step should be the analysis of the
existing pool of information by matching new gels
against protein patterns provided by databases. Im-
portant for such studies is the availability of compre-
hensive, user-friendly software packages that link
new gel patterns with online databases via the Inter-
net. If users request more information about proteins
they had identified by the 2D-gel analysis, these
 .software packages e.g., MELANIE, PDQuest auto-
matically open one of the Internet browsers such as
Netscape Navigator, and query the specified database
w xfor the protein of interest 4,43 . Computer Programs
such as MELANIE, can directly access the SWIS-
PROT, SWISS-2DPAGE, SWISS-3DIMAGE
 .databases. Other 2D-gel databases see Table 2 ,
EMBL GenBank, Medline, Brookhaven Structure
Database and many more, can also be reached by
hypertext links provided in the ExPASy Expert Pro-
.tein Analysis System; http:__expasy.hcug.ch file
w xserver in Geneva, Switzerland 4,44,45 .
4. Data integration and outlook
The comparison of mRNA and protein expression
profiles of normal and altered cells or tissues offers a
challenge for modern biomedical sciences. This infor-
mation, together with the information available from
protein and DNA databases as well as the forthcom-
ing mapping and sequencing data from the Human
Genome Project will provide an integrated picture of
a disease state, development of an embryo affected
by a genetic disorder, spreading of an infection and
particularly in the evolution of a neoplastic popula-
 .tion in the host Celis et al. 1994 . In order to find
targets for medical therapy, mechanisms leading to
these changes have to be defined. In the first place
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one has to be able to clearly define two compared
 .samples ‘‘normal vs. pathologic’’ on all three lev-
 .els, i.e. genome DNAs , currently expressed genes
 .RNAs , and protein composition, and further indi-
cate their differences. Computer accessible genome
and proteome databases contain a plethora of qualita-
tive and quantitative biological information which
can be used to support integrative research, e.g. in
cancer, differentiation, development, genetic linkage
analysis in disease and drug development and testing.
5. Final remarks
Based on the experience of our laboratory and
after discussions with many colleagues in the field,
we cannot recommend to the potential user any of the
techniques described in this review as the universal
solution for a successful screen of all differentially
expressed genes or proteins in any given system. In
an ideal case, for an exhaustive search, best would be
the combination of several of those. However, feasi-
bility of such an approach strongly depends on re-
sources available in the lab. It is always wise to
balance the ‘‘pros’’ and ‘‘conts’’ and decide for such
a technique which fits best the goal of the study
comparison of two different state of the same cell;
cataloging of all expressed genes or proteins in one
system; time course differences following a special
.treatment etc. . A generally valid rule is that any one
of these techniques is only as good as is the quality
of the starting material. This includes criteria used for
the choice of the right cellular background cell lines
.vs. tissue or organ samples ; the way how samples
are prepared e.g. problems with acquisition of truly
RNA-quality samples from human materials from
.surgeries as well as handling and halflife of actual
samples. From this point of view 2D-gel elec-
trophoresis of proteins has certainly an advantage
 .over DD analysis of RNA resp. mRNA samples.
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